13:42 IST
NSE
Results UpdateMarksans Pharma Ltd MARKSANS
Marksans Pharma Results Update
Marksans Pharma reported Q2FY27 revenue of ₹940 crore and H1FY27 PAT of ₹303 crore. EBITDA grew 48% to a record ₹214 crore in the quarter.
Marksans Pharma results update announcements
Every Marksans Pharma results update announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
13:30 IST
BSE
Results UpdateMarksans Pharma Ltd MARKSANS
Marksans Pharma Results Update
Marksans Pharma reported a record FY26 total income of ₹3,033.5 Crore, up 12.8% YoY. The company achieved historic highs in revenue, EBITDA, and PAT during the year.
- Value
- ₹3,034 Cr